Provectus Biopharmaceuticals, Inc. (PVCT)

PVCT Revenue

Provectus Biopharmaceuticals had revenue of $57.48K in the quarter ending June 30, 2025, a decrease of -77.46%. This brings the company's revenue in the last twelve months to $460.19K, down -32.71% year-over-year. In the year 2024, Provectus Biopharmaceuticals had annual revenue of $617.14K with 10.66% growth.

• Revenue (ttm): 460.19K
• Revenue Growth: -32.71%
• P/S Ratio: 64.65
• Revenue / Employee: 76.70K
• Employees: 6
• Market Cap: 29.75M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	617.14K	59.43K	10.66%
Dec 31, 2023	557.71K	-431.33K	-43.61%
Dec 31, 2022	989.04K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-